Replies to post #916 on Mosaic ImmunoEngineering Inc (CPMV)

[Poker MVP]

Ok, but I expect the global market share to exceed 4%. I'm sorry, but I don't understand your ROCE analysis.

IMO there will be no buy-out as it requires majority shareholder approval (which involves TPL once they have exercised their warrants).

AMD and INTC license agreements validates the joint patent portfolio - worldwide. And for those who oppose and do not acknowledge the joint patent portfolio, TPL should file civil complaints for infringement in federal court t/w immediete requests for TROs and preliminary injunctions.

Clock is ticking to 2015.